• Info
  • Insider Trading

Kathryn E. Falberg - Insider Trading & Ownership

Location
C/O Axovant Sciences, Inc., 320 West 37 Th Street, 5 Th Floor, New York, NY
Summary
The estimated net worth of Kathryn E. Falberg is at least $10.3M dollars as of June 12, 2025. Kathryn E. Falberg is the Director of Trade Desk, Inc. and owns shares of Trade Desk, Inc. (TTD) stock worth about $8.9M. Kathryn E. Falberg is the Director of Arcus Biosciences, Inc. and owns shares of Arcus Biosciences, Inc. (RCUS) stock worth about $1.39M.
Signature
/s/ Carolyn Tang, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Kathryn E. Falberg files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Kathryn E. Falberg

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TTD Trade Desk, Inc. Director $8.9M May 27, 2025
RCUS Arcus Biosciences, Inc. Director $1.39M Jun 10, 2025
NUVB, NUVB-WT Nuvation Bio Inc. Director May 21, 2025
TCDA Tricida, Inc. Director Jun 15, 2022
URGN UroGen Pharma Ltd. Director Jun 7, 2021

Insider Transactions Reported by Kathryn E. Falberg:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.